CHAPEL HILL, N.C.--(BUSINESS WIRE)--Sep. 15, 2015--
POZEN Inc. (NASDAQ: POZN), a specialty pharmaceutical company, today
announced that certain members of the executive management team will
participate in the Ladenburg Thalmann Healthcare Conference to be held
September 29, 2015 in New York. Adrian Adams, Chief Executive Officer,
is scheduled to present an overview of the Company at 3:00 p.m. ET on
Tuesday, September 29, 2015.
The presentation will also be webcast on the POZEN website under the
“Events” section on September 29, 2015. To access the live webcast,
please log on to POZEN’s site approximately 15 minutes prior to the
presentation to register and download any necessary audio software. The
presentation replay will be available for 90 days after the event.
POZEN Inc. is a specialty pharmaceutical company that to date has
historically focused on developing novel therapeutics for unmet medical
needs and licensing those products to other pharmaceutical companies for
commercialization. By utilizing a unique in-source model and focusing on
integrated therapies, POZEN has successfully developed and obtained FDA
approval of two self-invented products. Funded by these
milestones/royalty streams, POZEN has created a portfolio of
cost-effective, evidence-based integrated aspirin therapies designed to
enable the full power of aspirin by reducing its GI damage.
POZEN’s common stock is traded under the symbol “POZN” on The NASDAQ
Global Market. For more detailed company information, including copies
of this and other press releases, please visit www.POZEN.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150915005139/en/
Source: POZEN Inc.
Bill Hodges, 919-913-1030
Chief Financial Officer
Executive Director, Investor Relations &